Search Results 951-960 of 18672 for hepatitis

  1. Living Donor Archives - Mayo Clinic News Network

    with chronic liver disease. It develops over time and may be caused a number of conditions including, hepatitis, genetics, alcohol overuse or cancer. Chronic ...

  2. Cholangiocarcinoma (bile duct cancer) - Doctors and departments - Mayo Clinic

    ... hepatitis, Hepatocellular carcinoma, Hepatopulmonary syndrome, Primary biliary cholangitis, Hepatitis infectious disease, Acute liver failure. Show more ...

  3. Infectious Diseases Clinical Trials - Mayo Clinic Research

    The primary purpose of the study is to establish a long-term nationwide registry of patients undergoing treatment with antiviral therapies for chronic hepatitis ...

  4. 9-30-2021 COVID-19 Media Only News Briefing: Treatments for COVID-19 - Mayo Clinic News Network

    'Our goal is to achieve a world without viral hepatitis'. Related Articles. Top 10 questions about breast cancer answered featured image. Cancer. Top 10 ...

  5. Visiting Medical Student Clerkships - Laboratory Medicine and Pathology, Clinical Microbiology (Minnesota)

    ... hepatitis / HIV. Objectives. To gain an overview and understanding of appropriate diagnostic microbiologic tests used to guide patient care. Specific goals.

  6. A Study to Assess the Safety, Tolerability, and Pharmacokinetics of BIIB078 in Adults With C9ORF72-Associated Amyotrophic Lateral Sclerosis - Mayo Clinic

    ... hepatitis C virus antibody. Current hepatitis B infection (defined as positive for hepatitis B surface antigen [HBsAg] and/or hepatitis B core antibody [HBcAb]) ...

  7. Elvitegravir, cobicistat, emtricitabine, and tenofovir alafenamide (oral route) - Side effects & dosage - Mayo Clinic

    Hepatitis B infection, history of or; Kidney failure, history of—Use with caution. May make these conditions worse. Kidney disease, severe or; Liver disease ...

  8. Drospirenone and ethinyl estradiol (oral route) - Side effects & dosage - Mayo Clinic

    Do not use this medicine together with medicine to treat hepatitis C virus infection, including ombitasvir/paritaprevir/ritonavir, with or without dasabuvir ( ...

  9. Cholangiocarcinoma (bile duct cancer) - Doctors and departments - Mayo Clinic

    ... hepatitis, Hepatocellular carcinoma, Hepatopulmonary syndrome, Primary biliary cholangitis, Hepatitis infectious disease, Acute liver failure. Show more ...

  10. Study Comparing Tarlatamab and Durvalumab Versus Durvalumab Alone in First-Line Extensive-Stage Small-Cell Lung Cancer (ES-SCLC) Following Platinum, Etoposide and Durvalumab (DeLLphi-305) - Mayo Clinic

    ... hepatitis C infection (participants with hepatitis C that achieve a sustained virologic response after antiviral therapy are allowed), or hepatitis B ...